GENZUM LIFE SCIENCES IN THE NEWS

Meet Genzum at CPhI Worldwide Conference
7 - 9 October 2014, Paris Nord Villepinte, France - To schedule a meeting, email us at: partnering@genzum.com. Read more at: http://www.cphi.com/europe/about/#sthash.ppI0qBAa.dpuf

Genzum Private Capital Raise
July 2014, Genzum successfully completes its Series B offering to private investors.

Genzum Initiates Bioequivalency Clinical Trial
June 2014, Genzum successfully initiates a global bioequivalency trial on a Ophthalmic ANDA product.

Genzum Establishes New Commercial Partnership
April 2014, Genzum establishes new commercial partnership for the development and out license of Genzum topical ANDA product with Tier 1 Pharmaceutical partner. Further details to be released.

Meet Genzum at DCAT Week 2014
March 2014, Waldorf Astoria Hotel, New York - To schedule a meeting, email us at: partnering@genzum.com. Read more at: http://www.dcat.org/pages/week_DCATWeek.aspx

Meet Genzum at AAPS Conference
11 - 13 November 2013, San Antonio, Texas - To schedule a meeting, email us at: partnering@genzum.com.Read more at:  http://www.aaps.org/Meetings_and_Professional_Development/Calendar/2013/2013_AAPS_Annual_Meeting_and_Exposition/

Meet Genzum at CPhI Worldwide Conference
22 - 24 October 2013, Messe Frankfurt Germany - To schedule a meeting, email us at: partnering@genzum.com. Read more at: http://www.cphi.com/europe/about/#sthash.ppI0qBAa.dpuf.

Genzum Initiates Phase III Clinical Trial>
October 2013, Genzum successfully initiates a Phase III Clinical BA/BE trial on its Ophthalmic ANDA product.

Genzum Commercial Partnership
July 2013, Genzum establishes new collaboration and commercial partnership for the development and out license of topical ANDA products. Further details to be released.

Genzum Scientific Advisory Board
July 2013, Genzum Scientific Advisory Board signs partnership deal with a top-tier topical brand company at the annual American Academy of Dermatology meeting. More at: http://www.aad.org/meetings/2013-summer-meeting

Genzum Ophthalmic ANDA FDA Submission
June 17th, 2013 Genzum in collaboration with its commercial partner, successfully filed an ANDA application with the FDA. Further details to be released.

Genzum Private Capital Raise
June 2013, Genzum successfully completes its Series A offering to private investors.

Genzum Topical Pipeline
January 2013, Genzum adds two topical ANDA development projects to existing product development collaboration with a tier 1 generic distributor. Further details to be released.

Genzum Phase III Clinical Trial
December 2012, Genzum successfully completes a Phase III Clinical trial on its Ophthalmic ANDA product.